SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950144-04-007638
Filing Date
2004-08-03
Accepted
2004-08-03 17:03:13
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 NOVEN PHARMACEUTICALS, INC. FORM 10-Q g90156e10vq.htm 10-Q 292367
2 AGREEMENT BETWEEN SHIRE US INC. AND NOVEN PHARMACEUTICALS g90156exv10w1.htm EX-10.1 23582
3 SECTION 302 CEO CERTIFICATION g90156exv31w1.htm EX-31.1 7604
4 SECTION 302 CFO CERTIFICATION g90156exv31w2.htm EX-31.2 7564
5 SECTION 906 CEO CERTIFICATION g90156exv32w1.htm EX-32.1 3322
6 SECTION 906 CFO CERTIFICATION g90156exv32w2.htm EX-32.2 3250
  Complete submission text file 0000950144-04-007638.txt   339879
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

IRS No.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17254 | Film No.: 04949132
SIC: 2834 Pharmaceutical Preparations